BRITANNIA PHARMACEUTICALS LIMITED
Get an alert when BRITANNIA PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£7.2m
+116.1% highest in 3 filed years
Net assets
£53m
-5.2% lowest in 3 filed years
Employees
101
+6.3% highest in 3 filed years
Profit before tax
£4.2m
-62.7% lowest in 3 filed years
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £76,537,000 | £85,448,000 | £82,221,000 | -3.8% | |
| Operating profit | £11,480,000 | £10,881,000 | £4,155,000 | -61.8% | |
| Profit before tax | £11,622,000 | £11,130,000 | £4,155,000 | -62.7% | |
| Net profit | £13,269,000 | £14,164,000 | £3,113,000 | -78% | |
| Cash | £3,627,000 | £3,330,000 | £7,196,000 | +116.1% | |
| Total assets less current liabilities | £53,979,000 | £55,907,000 | £54,618,000 | -2.3% | |
| Net assets | £53,323,000 | £55,487,000 | £52,600,000 | -5.2% | |
| Equity | £53,323,000 | £55,487,000 | £52,600,000 | -5.2% | |
| Average employees | 87 | 95 | 101 | +6.3% | |
| Wages | £5,727,000 | £5,530,000 | £6,059,000 | +9.6% | |
| Directors' remuneration | £380,000 | £643,000 | £517,000 | -19.6% | |
| Directors' pension contributions | £14,000 | £21,000 | £15,000 | -28.6% | |
| Highest paid director | £394,000 | £643,000 | £517,000 | -19.6% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 15.0% | 12.7% | 5.1% | |
| Net margin | 17.3% | 16.6% | 3.8% | |
| Return on capital employed | 21.3% | 19.5% | 7.6% | |
| Gearing (liabilities / total assets) | 26.3% | 26.2% | 29.9% | |
| Current ratio | 2.22x | 2.30x | 2.18x | |
| Interest cover | — | — | 31.24x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company is expected to be profitable and cash generative for the foreseeable future. The Company has no third party debt and positive net current assets... directors have obtained a letter of support from the Company's parent”
Group structure
- BRITANNIA PHARMACEUTICALS LIMITED · parent
- CNRD 2002 Limited 33%
Significant events
- “During the year, the ultimate shareholders of the Company's intermediate parent, Stada Arzneimittel AG agreed the sale of a majority stake in Stada Arzneimittel AG to CapVest Partners LLP. The transaction completed on 31 March 2026.”
- “Subsequent to the reporting date, the Group commenced a restructuring of its UK operations as part of a wider organisational review, which is expected to result in changes to the operational structure of the UK business.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 33 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GRANT, Victoria Louise | Director | 2026-07-31 | Apr 1984 | British |
Show 33 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FORSHAW, John Robert | Secretary | 2006-03-22 | 2007-09-20 |
| GALLEHAWK, Andrew Ralph | Secretary | 2019-10-01 | 2020-06-29 |
| GORE-STRACHAN, Evelyn | Secretary | 2013-07-11 | 2015-06-29 |
| HANLON, James Anthony | Secretary | 2007-09-20 | 2010-05-17 |
| PEFFERS, Douglas Watson | Secretary | 2004-04-29 | 2006-03-22 |
| PEFFERS, Douglas Watson | Secretary | — | 1992-10-21 |
| ROBINSON, Elizabeth | Secretary | 2016-04-05 | 2019-10-01 |
| SHEPARD, John Anthony | Secretary | 1992-10-21 | 2004-04-29 |
| WRIGHT, Philip John | Secretary | 2010-05-17 | 2013-07-11 |
| BALLARD, Peter Gavin | Director | 2008-08-13 | 2012-05-03 |
| DAVIES, David Keith | Director | — | 2007-09-20 |
| DENGLER, Christoph | Director | 2015-06-09 | 2021-02-22 |
| DUCKWORTH, Alexander James | Director | 2001-10-10 | 2007-09-20 |
| DUCKWORTH, Peter Edgar | Director | — | 2007-09-20 |
| GERARD, William Wilson | Director | — | 2007-09-20 |
| GRANT, Victoria Louise | Director | 2022-09-07 | 2022-10-03 |
| HANLON, James Anthony | Director | 2007-09-20 | 2010-05-17 |
| HASLAM, David | Director | 2009-02-12 | 2010-05-17 |
| HASLAM, David Nicholas | Director | 2000-10-19 | 2007-09-20 |
| HUTCHINSON, David John Mckenzie | Director | 2006-09-14 | 2007-09-20 |
| JACKSON-DOOLEY, Brian Maxwell | Director | 1994-12-21 | 2005-12-31 |
| JARVIS, Helen Ann | Director | 2006-09-14 | 2007-09-20 |
| JEBING, Dieter | Director | 2012-05-03 | 2016-04-05 |
| NOBLE, Maxwell Edward Paul | Director | — | 2007-09-20 |
| O'RIORDAN, Rory Walter | Director | 2007-09-20 | 2010-05-17 |
| PEFFERS, Douglas Watson | Director | — | 2007-09-20 |
| PRICE, Ian Roger | Director | 2004-04-29 | 2007-09-20 |
| SCARLETT-SMITH, Roger Lidderdale | Director | 2021-02-22 | 2022-09-07 |
| SLEGERS, Luc Maurice Godelieva | Director | 2007-09-20 | 2015-06-29 |
| TIERNEY, Daniel Peter Nicholas | Director | — | 2007-09-20 |
| WOOD, Robert Kenneth | Director | 2016-04-05 | 2026-07-31 |
| WOODCOCK, Derek Alan | Director | 1994-12-21 | 2007-09-20 |
| WRIGHT, Philip John | Director | 2008-08-13 | 2010-05-17 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Genus Pharmaceuticals Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 191 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-30 | AA | accounts | Accounts with accounts type full | |
| 2026-08-04 | TM01 | officers | Termination director company with name termination date | |
| 2026-08-04 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-01 | AA | accounts | Accounts with accounts type full | |
| 2025-08-07 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-05-08 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-01-15 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-11-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-19 | AA | accounts | Accounts with accounts type full | |
| 2024-08-01 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-11-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-10 | AA | accounts | Accounts with accounts type full | |
| 2023-02-21 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-11-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-24 | AAMD | accounts | Accounts amended with accounts type full | |
| 2022-11-03 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-10-03 | TM01 | officers | Termination director company with name termination date | |
| 2022-09-07 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-07 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.